Answers are grounded in this paper and cite their sources.
Reveals improved survival with perioperative chemotherapy in gastroesophageal adenocarcinoma, highlighting the benefit of systemic treatment around surgery.
In patients with resectable adenocarcinoma of the lower esophagus, GEJ, or stomach, perioperative chemotherapy using fluorouracil plus cisplatin significantly increased the curative resection rate, disease-free survival, and OS.
No takes yet. Share an insight, caveat, or question.
Ychou et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: